APA

Wasserman R. L., Church J. A., Stein M., Moy J., White M., Strausbaugh S., Schroeder H., Ballow M., Harris J., Melamed I., Elkayam D., Lumry W., Suez D. & Rehman S. M. (20130122). Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency. : Journal of clinical immunology.

Chicago

Wasserman Richard L, Church Joseph A, Stein Mark, Moy James, White Martha, Strausbaugh Steven, Schroeder Harry, Ballow Mark, Harris James, Melamed Isaac, Elkayam David, Lumry William, Suez Daniel and Rehman Syed M. 20130122. Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency. : Journal of clinical immunology.

Harvard

Wasserman R. L., Church J. A., Stein M., Moy J., White M., Strausbaugh S., Schroeder H., Ballow M., Harris J., Melamed I., Elkayam D., Lumry W., Suez D. and Rehman S. M. (20130122). Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency. : Journal of clinical immunology.

MLA

Wasserman Richard L, Church Joseph A, Stein Mark, Moy James, White Martha, Strausbaugh Steven, Schroeder Harry, Ballow Mark, Harris James, Melamed Isaac, Elkayam David, Lumry William, Suez Daniel and Rehman Syed M. Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency. : Journal of clinical immunology. 20130122.